Trueblood Wealth Management’s First Trust Large Cap Value AlphaDEX Fund FTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78M Buy
40,958
+56
+0.1% +$5.13K 1.48% 8
2025
Q4
$3.52M Buy
40,902
+1,275
+3% +$107K 1.38% 8
2025
Q3
$3.3M Buy
39,627
+537
+1% +$43.7K 1.29% 9
2025
Q2
$3.07M Buy
39,090
+1,857
+5% +$139K 1.29% 9
2025
Q1
$2.86M Buy
37,233
+1,891
+5% +$147K 1.33% 9
2024
Q4
$2.7M Buy
35,342
+1,734
+5% +$138K 1.33% 6
2024
Q3
$2.66M Buy
33,608
+7,773
+30% +$594K 1.34% 6
2024
Q2
$1.9M Buy
25,835
+2,049
+9% +$152K 1.07% 16
2024
Q1
$1.82M Buy
23,786
+1,437
+6% +$103K 1.04% 15
2023
Q4
$1.58M Buy
+22,349
New +$1.48M 0.99% 19

Other funds holding FTA

Trueblood Wealth Management's FTA Position: Q1 2026 in Review

Trueblood Wealth Management increased its First Trust Large Cap Value AlphaDEX Fund (FTA) stake by 0.14% in Q1 2026, buying an estimated $5.13K and bringing the position to 40,958 shares worth $3.78M. The position accounts for 1.48% of the portfolio, ranked #8.

Trueblood Wealth Management first reported a position in FTA in Q4 2023 and has held it in 10 quarters since. 218 funds tracked by Wall St. Rank hold FTA as of Q1 2026.

  • Trueblood Wealth Management held 40,958 shares of First Trust Large Cap Value AlphaDEX Fund worth $3.78M as of Q1 2026.
  • Trueblood Wealth Management bought 56 First Trust Large Cap Value AlphaDEX Fund shares in Q1 2026, an estimated $5.13K.
  • First Trust Large Cap Value AlphaDEX Fund made up 1.48% of Trueblood Wealth Management's portfolio in Q1 2026, its #8 holding.
  • Trueblood Wealth Management first reported a position in First Trust Large Cap Value AlphaDEX Fund in Q4 2023 and has held it in 10 quarters since.
  • 218 funds tracked by Wall St. Rank held First Trust Large Cap Value AlphaDEX Fund as of Q1 2026.

Based on Trueblood Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.